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Abstract The early diagnosis of visceral leishmaniasis
(VL) using Direct Agglutination Tests (DAT) and its
treatment and control are essential actions taken in rural
health centers in endemic foci of the infection based on the
national protocols set by the Iranian Ministry of Health and
Medical Education. Eleven clinically confirmed VL
patients with typical VL symptoms and negative results of
DAT, admitted to the pediatrics department of Valiasr
Hospital in Meshkinshahr underwent parasitological tests.
7 of the total of 11 patients had positive result of bone
marrow puncture smears and all of them had negative
results of DAT. Thus factors that had led to false negative
DAT results were examined. The patients’ blood samples
were collected in microhematocrit tubes using the finger
prick technique, centrifuged and their plasma then sepa-
rated. The complete medical history of the patients was
taken using a questionnaire. The laboratory staff therefore
checked the quality of anti-leishmania antigen, materials
and equipment used. The patients’ medical history showed
that they had all been administered corticosteroid
medications such as dexamethasone or hydrocortisone
prior to visiting the laboratory. The DAT was repeated in
these patients 2–3 weeks after their last administration of
corticosteroids. The antibody titers were positive this time.
A total of 3 of the collected specimens (27.3 %) showed a
titer of 1.3200, 5 (46 %) showed a titer of 1.1600 and 3
(27.3 %) a titer of 1.800. Due to the effects of some
medications, particularly corticosteroids, on serological
tests, the patients’ full medical history should be taken
prior to performing this test and physicians working at
endemic regions of this infection should be notified about
these drug interactions.
Keywords Visceral leishmaniasis  Direct Agglutination
Test  False negative  Corticosteroid
Introduction
Mediterranean visceral leishmaniasis (VL) or Kala-Azar is
a vector-borne parasitic disease with at least six endemic
foci in northwestern and southern of Iran (Mohebali 2013).
Wild carnivores (such as foxes and jackals) and domestic
dogs act as the main sources of the transmission of
Leishmania infantum while wild rodents (such as the gray
hamster) act as secondary sources of its transmission in
Iran (Mohebali et al. 2005, 2004). VL is transmitted by
various species of phlebotomine sand flies (Azizi et al.
2008; Oshaghi et al. 2009; Absavaran et al. 2009; Rassi
et al. 2012a, b). The laboratory diagnosis of VL is critical
due to the high fatality rates of the infection (up to 100 %)
if left untreated (Mohebali 2013). Parasitological, sero-
logical and molecular methods are used for the diagnosis of
human VL (Mohebali et al. 2006). DAT is a serological test
available for the diagnosis of VL that is highly specific and
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sensitive, cost-effective, reliable, safe and adaptable to
microtiter plates (Edrissian et al. 1996). Any factor that
interferes with the results of DAT can cause negative false
results and lead to errors in the diagnosis of the infection.
This present study was conducted in Kala-Azar laboratory
of Meshkinshahr Health Center due to the of negative DAT
results in eleven clinically and parasitology confirmed VL
patients. It should be noted that 7 of the total of 11 cases
had positive parasitological test results.It may showed low
sensitivity of bone marrow puncture smears versus sero-
logical tests.
Materials and methods
Study area
The present study was conducted in Meshkinshahr, Ardabil
province, northwest of Iran, where VL is endemic.
Meshkinshahr is a region in central north Ardabil located at
an altitude of 1490 m above sea level, at the longitude of
47.190N and 48.170E and the latitude of 38.570N and
38.130E. A total of 42 % of Meshkinshahr’s population
resides in urban areas, 58 % lives in rural areas, and a small
population has instead adopted a nomadic lifestyle.
Questionnaires were used to record the personal infor-
mation, clinical data and symptoms of the VL patients
admitted to Valiasr Hospital and Kala-Azar laboratory.
Blood sampling
For the blood sampling, the middle finger of the patient
was disinfected with 70 % alcohol and then punctured by
lancets after the alcohol had dried. The blood samples were
then taken to the laboratory in microhematocrit tubes,
centrifuged at 3000 rpm for 5–10 min and then had its
plasma separated for the DAT.
DAT test
V-shaped microtiter plates were used to perform the DAT.
The Leishmania infantum antigens for this study were
prepared in the Parasitology Laboratory, School of Public
Health, Tehran University of Medical Science (Edrissian
et al. 1996). The principal phases of the procedure for
preparing the DAT antigen were mass production of pro-
mastigotes of leishmania infantum (Iranian strain) in RPMI
1640 medium, supplemented with 10 % fetal bovine
serum, trypsinization of the parasites, staining with Coo-
massie Brilliant blue and fixing with 2 % formalde-
hyde(Mohebali et al. 2005; el Harith et al. 1989; Harith
et al.1986).
At first, serum dilutions were made from 1.800 and
1.3200 titers. Samples with a 1.800 titer were diluted fur-
ther for an end-point dilution of 1.102400. The negative
and positive controls were tested in each plate. The results
were read after 12–18 h incubation in a wet room at room
temperature. The titer was defined as the highest dilution at
which agglutination was still visible in comparison with
positive and negative controls. Compact blue dots were
scored as negative and large diffuse blue mats as positive
(Harith et al. 1986).
Results
In the present study, of the total of 11 confirmed VL cases,
8 (72.7 %) were male and 3 were female (27.3 %). Four
(36.4 %) of the patients were under the age of 2, 5 were
aged 2–5 (45.5 %) and 2 were aged over 5 (18.1 %).
Patients admitted to the laboratory had shown general
flulike symptoms, such as anorexia, malaise, fever and
diarrhea, as well as typical VL symptoms, such as fever,
anemia and splenomegaly. Seven (64 %) of the patients
were hospitalized and 4 (36 %) were referred to the labo-
ratory. The patients’ clinical manifestations had created the
expectation of finding positive DAT results; however, all
the samples showed negative reactions. The Pediatricians
at Valiasr Hospital of Meshkinshahr insisted on their
diagnosis of visceral leishmaniasis. In seven patients, the
bone marrow aspiration confirmed the diagnosis. After the
occurrence of false negative DAT, the quality of all the
laboratory material, equipment, buffers, diluents and anti-
gens was controlled and the DAT was repeated, showing a
negative reaction.Then investigate history of patients. All
the patients had been administered corticosteroid medica-
tions such as dexamethasone or hydrocortisone prior to
admission to hospital or laboratory. The third DAT was
performed 2–3 weeks after the patients’ last administration
of corticosteroids. Surprisingly, the test showed positive
reactions this time. The titers ranged from 1.800 to 1.6400,
with 3 cases (27 %) having a titer of 1.800, 5 cases (46 %)
a titer of 1.1600 and 3 cases (27 %) a titer of 1.6400
(Table 1).
Discussion
DAT has been used extensively over the last decade for
seroepidemiological studies of VL (Mohebali et al. 2005).
Features such as high specificity, sensitivity, simplicity,
safety, cost-effectiveness, adaptability to microtiter plates
and field applicability have led to the extensive application
of DAT in VL endemic regions of Iran (Mohebali 2013;
Dehkordi et al. 2011). Researchers have examined the
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factors affecting the sensitivity and specificity of DAT,
including technical factors and the quality of materials,
equipment, buffers and antigens used (Akhoundi et al.
2012; Mohebali et al. 2011). Researchers have also
examined other patient-related factors, including the stage
of the disease such as acute, subacute or chronic phases
(Harith et al. 1986). All the patients admitted to Kala-Azar
Laboratory had presented typical symptoms of VL, but
their DAT had shown an unexpected negative resultss. The
accuracy of the DAT performed was verified through the
control of the anti-Leishmania antigens and the laboratory
materials and equipments. The patients’ medical history
was carefully taken from their parents. The patients had
been administered corticosteroids drugs such as dexam-
ethasone and hydrocortisone prior to admission to Kala-
Azar laboratory by other physicians to help relieve symp-
toms such as malaise, fever, rash and allergy. Corticos-
teroid medications were assumed to have affected the
body’s immune system, suppressed the B lymphocytes and
inhibited the production of antibodies, thereby leading to
the DAT showing false negative reactions.
Both cellular and humoral immunity interfere with
immunity to Leishmania; however, cellular immunity is
more crucial to immunization while humoral immunity is
crucial to the diagnosis of sera. The number of leishma-
niasis cases associated with immunosuppressants has been
increasing over the past 20 years. HIV immunosuppressive
agents, immunosuppressive treatments, organ transplanta-
tion and neoplastic diseases increase the risk for the
Leishmania-infected to develop visceral diseases (Pittalis
et al. 2006). Circulating B lymphocytes are reduced with
the administration of glucocorticoids, especially through
changing the Ab production patterns; low doses of gluco-
corticoids, however, appear to have little, if any, effect on
the production of antigen stimulated antibodies (Tuon et al.
2007).
Further studies on the subject are recommended to
confirm the findings of the present study. Physicians
working in endemic regions must be familiar with leish-
maniasis and their diagnostic tests and should also avoid
the administration of medications such as glucocorticoids
prior to performing serological tests.
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